Global footprint Excerpts presence in Amsterdam, London, and Philadelphia combined with a global network through Omnicom and Adelphi suggests an opportunity to offer cross-market medical communications programs, international expansion support, and transatlantic publications management to clients seeking consistent branding and regulatory alignment.

Lifecycle expertise Strong focus on strategic consultancy and lifecycle management positions the company to upsell end-to-end programs for product launches, life-cycle updates, and post-launch market access communications to pharma companies seeking integrated solutions.

Therapeutic breadth Deep experience in oncology, diabetes, cardiology, and thrombosis indicates potential for targeted outreach to biotech and pharma firms with assets in these areas, including surgical and digital engagement campaigns tailored to specialist audiences.

Regulatory excellence Emphasis on industry-standard SOPs and regulatory compliance enables selling for high-stakes medical education and publication projects with strict guidelines, appealing to sponsors that require rigorous governance and audit-ready deliverables.

Mid-market fit Revenue range and employee size place Excerpta Medica in the mid-market segment, presenting opportunities to partner with mid-sized pharma and biotech firms seeking scalable medical communications, digital engagement, and publication planning at a value-driven price point.